Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
02/2002
02/07/2002US20020016458 Intramolecular glycosidation process for the synthesis of (2R, 2-alpha-R, 3A)-2-[1-(3,5- BIS (trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine
02/07/2002US20020016365 Nonsteroidal gestagens
02/07/2002US20020016337 Heterocyclic analgesic compounds and methods of use thereof
02/07/2002CA2417444A1 Nonsteroidal inflammation inhibitors
02/06/2002EP1178039A1 Derivatives of phenyl(thio)urea and phenyl(thio)carbamate fungicides
02/06/2002EP0971917B1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties
02/06/2002EP0882024B1 Retroviral protease inhibiting compounds
02/06/2002CN1334813A Method for preparing (R)-(+)-3-{1-[2-(4-benzoyl-2-(3,4-difluorophenyl) morpholin-2-yl)ethyl]-4-phenylpiperdin-4-yl}-1,1-dimethylurea, its salts solvates and/or hydrates
02/06/2002CN1334809A Nonsteroidal antiinflammatories
02/05/2002US6344454 Contraceptive preparations,treatment of endometriosis, gynecological disorders,premenstrual symptoms, male birth control, male hrt and hormone therapy and for treating andrological disease agents.
01/2002
01/31/2002WO2001070682A3 Carbocyclic side chain containing metalloprotease inhibitors
01/31/2002US20020013497 Alkylation, blocking
01/31/2002US20020013314 For treating or preventing thrombosis
01/30/2002EP1175412A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
01/30/2002EP1175411A1 Cyclothiocarbamate derivatives as progesterone receptor modulators
01/30/2002EP1175404A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
01/30/2002EP1175390A1 Disodium salts, monohydrates, and ethanol solvates
01/30/2002CN1333750A Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
01/29/2002US6342633 O-benzyl oxime ether derivatives and their use as pesticides
01/29/2002US6342496 Bupropion metabolites and methods of use
01/29/2002US6342379 Detection of transmembrane potentials by optical methods
01/24/2002US20020010085 Hydrogenation catalyst
01/23/2002EP1173427A1 Hydroxamic acid derivative
01/23/2002EP1173426A1 Cyclocarbamate derivatives as progesterone receptor modulators
01/23/2002EP1173415A1 Diphenylurea derivatives
01/23/2002EP1173206A1 Contraceptive compositions containing quinazolinone and benzoxazine derivatives
01/23/2002EP1173183A2 Use of compounds with a nitrogen-oxygen heterocycle
01/23/2002CN1332727A 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
01/23/2002CN1332724A N-arylsulfonyl amino acid omega amides
01/23/2002CN1332719A Method for preparation of aryl ethers
01/22/2002US6340599 Terbium, dysprosium, samarium, osmium, or ruthenium complex with unsaturated oxyaryl compound
01/17/2002WO2002004444A2 Heterocycle carboxamides as antiviral agents
01/17/2002WO2002004431A1 Silent mark for oil product and detection method thereto
01/17/2002WO2001042211A3 Detection of transmembrane potentials by optical methods
01/16/2002EP1171431A1 Compounds, their preparation and use
01/16/2002EP1171430A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and pharmaceutical compositions containing them
01/16/2002CN1331680A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors
01/16/2002CN1331675A Novel herbicides
01/16/2002CN1077886C Amidino derivatives useful as nitric oxide synthase inhibitors
01/10/2002WO2002002539A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
01/10/2002WO2001026641A3 Morpholinol derivatives for the treatment of obesity
01/10/2002US20020004503 Viricides
01/10/2002US20020004501 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
01/10/2002US20020004494 Muscular disorders, gastrointestinal disorders, respiratory system disorders
01/10/2002CA2414461A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
01/09/2002EP1170289A2 Retroviral protease inhibiting compounds
01/09/2002EP1169308A1 Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils
01/09/2002EP1169300A1 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof
01/09/2002EP1112259A4 Process for the synthesis of n-benzyl-3-(4-fluorophenyl)-1,4-oxazin-2-one
01/08/2002US6337328 Bupropion metabolites and methods of use
01/03/2002WO2002000631A2 Benzhydryl derivatives
01/03/2002US20020002164 Morpholine and thiomorpholine tachykinin receptor antagonists
01/02/2002EP1165528A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
01/02/2002EP1165516A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
01/02/2002EP1165515A1 Pyridine-2,3-dicarboxylic acid diamides
01/02/2002EP1165496A1 Substituted aniline compounds
01/02/2002EP1165086A2 Bupropion metabolites and methods of their synthesis and use
01/02/2002CN1329002A Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide
01/02/2002CN1076949C Crop protective products
01/01/2002US6335338 Calcilytic compounds
01/01/2002US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis
01/01/2002US6335333 Matrix metalloproteinase inhibitors
12/2001
12/27/2001WO2001098256A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
12/26/2001CN1328545A Hydrazine derivatives
12/26/2001CN1327976A Benzoxazinone compounds asymmetrically synthesized from new intermediate
12/25/2001US6333413 Pyridazin-3-one derivatives by cyclizing the carboxy-substituted hydrazone
12/20/2001WO2001096320A1 Intramolecular glycosidation process for the synthesis of (2r, 2-alpha-r, 3a)-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine
12/20/2001WO2001096319A1 Trans-glycosidation process for the synthesis of (2r, 2-alpha-r, 3a)-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine
12/20/2001WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents
12/20/2001WO2001016108A3 Bicyclic androgen and progesterone receptor modulator compounds and methods
12/20/2001US20010053789 Phenolic compounds; antidepressants; plant and animal extracts
12/19/2001EP1163262A1 Phenylalanine derivatives
12/18/2001US6331627 Intermediates of benzoxazinone derivatives and preparation thereof
12/18/2001US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
12/13/2001WO2001094324A1 Process for the synthesis of (2r, 2-alpha-r, 3a)-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine
12/13/2001WO2001094323A1 Process for the synthesis of (2r, 2-alpha-r)-4-benzyl-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-1,4-oxazin-3-one
12/13/2001WO2001094322A1 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof
12/13/2001WO2001094301A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use
12/13/2001US20010051619 E.g., ethyl 3-(4-(2-(3-oxo-2H-1,4-benzoxazin-4-yl)ethoxy)-phenyl-2-ethoxypropenoate where 1,4-benzothiazine or quinoxaline can be substituted for the benzoxazine ring; anticholesterol, diabetic agents; obesity; hyperlimpidemia
12/13/2001CA2410404A1 Process for the synthesis of (2r, 2-alpha-r, 3a)-2-¬1-(3,5-bis(trifluoromethyl)phenyl)ethoxy|-3-(4-fluorophenyl)-1,4-oxazine
12/12/2001EP1162194A1 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use
12/12/2001EP1161233A2 Lxr modulators
12/12/2001EP0889936B1 Cationically polymerizable compositions capable of being applied by electrostatic assistance
12/12/2001EP0656893B1 Photochromic oxazine compounds
12/12/2001CN1326473A Supported group 8-10 transition metal olefin polymerization catalysts
12/06/2001WO2001092226A1 Heterocyclic analgesic compounds and method of use thereof
12/05/2001EP1159254A1 Oxyalkylene-substituted aminophenol intermediate
12/05/2001CN1325384A Anthranilic acid amides and the use thereof as medicaments
12/05/2001CN1075812C Prodrugs of morpholine tachykinin receptor antagonists
11/2001
11/29/2001WO2001090088A1 Method for making acylamides by synthesizing and acylating benzoxazines
11/29/2001WO2001090082A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/28/2001EP1156798A1 Felbamate derived compounds
11/28/2001EP1156794A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen
11/28/2001CN1075499C Quninolone-acid naphthyridone carboxylic acid derivatives
11/27/2001US6323367 Reacting tertiary or secondary amine with hydrogen peroxide as an oxidant in presence of a recyclable heterogeneous layered double hydroxide exchanged with transition metal oxides as a catalyst in an organic solven, stirring, filtration
11/27/2001US6323199 Aromatic heterocyclic hydroxy amines or amides for treatment of inflammation
11/27/2001US6323154 3-aryluracils and intermediates for their preparation
11/22/2001WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001WO2001087862A2 Biologically active 4h-benzo[1,4]oxazin-3-ones
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 112